Blueprint Medicines (BPMC) develops what it calls precision therapies that take advantage of the company's expertise in protein kinases, which are types of enzymes that regulate a protein's biological activity. As you might have guessed, the science here is way above my pay grade, but I like what I am seeing on the charts. Let's check.
More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
Looking to eliminate company-specific risk? Here's how I'd play these two popular exchange-traded funds.
Selecting and buying the right shares produces big profits -- but only when the conditions are right.
Military contractors tend to have strong performance, even amid recessions. Here are three names that could provide steady income now.